Literature DB >> 31242520

Heterogeneity of Macrophages in Atherosclerosis.

Christopher Stremmel1,2, Konstantin Stark1,2, Christian Schulz1,2.   

Abstract

Atherosclerosis is a prevalent inflammatory condition and a frequent cause of morbidity and mortality worldwide. Macrophages are among the key immune cells driving lesion formation in the arterial wall. They have therefore evolved as potential targets for therapeutic strategies. Understanding of the different macrophage phenotypes and functions seems to be of pivotal importance for the development of treatments to target these immune cells. This review highlights the complexity of the mononuclear phagocyte system and summarizes important features of macrophage biology contributing to atherosclerosis. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31242520     DOI: 10.1055/s-0039-1692665

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  2 in total

1.  Inhibition of microRNA-494-3p activates Wnt signaling and reduces proinflammatory macrophage polarization in atherosclerosis.

Authors:  Eva van Ingen; Amanda C Foks; Tamar Woudenberg; M Leontien van der Bent; Alwin de Jong; Philipp J Hohensinner; Johann Wojta; Ilze Bot; Paul H A Quax; Anne Yaël Nossent
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-04       Impact factor: 8.886

2.  Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice.

Authors:  Qingxia Zhao; Zhan Wang; Allison K Meyers; Jennifer Madenspacher; Manal Zabalawi; Qianyi Zhang; Elena Boudyguina; Fang-Chi Hsu; Charles E McCall; Cristina M Furdui; John S Parks; Michael B Fessler; Xuewei Zhu
Journal:  Front Cardiovasc Med       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.